Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer

被引：189
作者：
Amatu, A. [1 ]
Sartore-Bianchi, A. [1 ,2 ]
Bencardino, K. [1 ]
Pizzutilo, E. G. [1 ,2 ]
Tosi, F. [1 ,2 ]
Siena, S. [1 ,2 ]
机构：
[1] Grande Osped Metropolitano Niguarda, Niguarda Canc Ctr, Dept Hematol & Oncol, Piazza Osped Maggiore 3, I-20162 Milan, Italy
[2] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
基金：
欧盟地平线“2020”;
关键词：
TRK; tropomyosin receptor kinase; NTRK gene fusions; TRK fusion cancer; NERVE GROWTH-FACTOR; TYROSINE PROTEIN-KINASE; NEUROTROPHIC FACTOR; MESOBLASTIC NEPHROMA; TARGETED THERAPY; CONGENITAL INSENSITIVITY; INHIBITOR ENTRECTINIB; PROTOONCOGENE PRODUCT; ACQUIRED-RESISTANCE; HIGH-FREQUENCY;
D O I：
10.1093/annonc/mdz383
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The tropomyosin receptor kinase (TRK) family of receptor tyrosine kinases are encoded by NTRK genes and have a role in the development and normal functioning of the nervous system. Since the discovery of an oncogenic NTRK gene fusion in colorectal cancer in 1986, over 80 different fusion partner genes have been identified in a wide array of adult and paediatric tumours, providing actionable targets for targeted therapy. This review describes the normal function and physiology of TRK receptors and the biology behind NTRK gene fusions and how they act as oncogenic drivers in cancer. Finally, an overview of the incidence and prevalence of NTRK gene fusions in various types of cancers is discussed.
引用
收藏
页码：VIII5 / VIII15
页数：11
相关论文
共 122 条
  • [81] CLONING AND CHROMOSOMAL LOCALIZATION OF THE HUMAN TRK-B TYROSINE KINASE RECEPTOR GENE (NTRK2)
    NAKAGAWARA, A
    LIU, XC
    IKEGAKI, N
    WHITE, PS
    YAMASHIRO, DJ
    NYCUM, LM
    BIEGEL, JA
    BRODEUR, GM
    [J]. GENOMICS, 1995, 25 (02) : 538 - 546
  • [82] Trk receptor tyrosine kinases: A bridge between cancer and neural development
    Nakagawara, A
    [J]. CANCER LETTERS, 2001, 169 (02) : 107 - 114
  • [83] NANDA N, 2015, J CLIN ONCOL S15, V33
  • [84] Analysis of NTRK Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics
    Okamura, Ryosuke
    Boichard, Amelie
    Kato, Shumei
    Sicklick, Jason K.
    Bazhenova, Lyudmila
    Kurzrock, Razelle
    [J]. JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 20
  • [85] ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer
    Pietrantonio, Filippo
    Di Nicolantonio, Federica
    Schrock, Alexa B.
    Lee, Jeeyun
    Tejpar, Sabine
    Sartore-Bianchi, Andrea
    Hechtman, Jaclyn F.
    Christiansen, Jason
    Novara, Luca
    Tebbutt, Niall
    Fuca, Giovanni
    Antoniotti, Carlotta
    Kim, Seung Tae
    Murphy, Danielle
    Berenato, Rosa
    Morano, Federica
    Sun, James
    Min, Bosun
    Stephens, Philip J.
    Chen, Marissa
    Cremolini, Chiara
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (12):
  • [86] PISHVAIAN MJ, 2018, J CLIN ONCOL S4, V36
  • [87] Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology
    Qaddoumi, Ibrahim
    Orisme, Wilda
    Wen, Ji
    Santiago, Teresa
    Gupta, Kirti
    Dalton, James D.
    Tang, Bo
    Haupfear, Kelly
    Punchihewa, Chandanamali
    Easton, John
    Mulder, Heather
    Boggs, Kristy
    Shao, Ying
    Rusch, Michael
    Becksfort, Jared
    Gupta, Pankaj
    Wang, Shuoguo
    Lee, Ryan P.
    Brat, Daniel
    Collins, V. Peter
    Dahiya, Sonika
    George, David
    Konomos, William
    Kurian, Kathreena M.
    McFadden, Kathryn
    Serafini, Luciano Neder
    Nickols, Hilary
    Perry, Arie
    Shurtleff, Sheila
    Gajjar, Amar
    Boop, Fredrick A.
    Klimo, Paul D., Jr.
    Mardis, Elaine R.
    Wilson, Richard K.
    Baker, Suzanne J.
    Zhang, Jinghui
    Wu, Gang
    Downing, James R.
    Tatevossian, Ruth G.
    Ellison, David W.
    [J]. ACTA NEUROPATHOLOGICA, 2016, 131 (06) : 833 - 845
  • [88] Broad Detection of Alterations Predicted to Confer Lack of Benefit From EGFR Antibodies or Sensitivity to Targeted Therapy in Advanced Colorectal Cancer
    Rankin, Andrew
    Klempner, Samuel J.
    Erlich, Rachel
    Sun, James X.
    Grothey, Axel
    Fakih, Marwan
    George, Thomas J., Jr.
    Lee, Jeeyun
    Ross, Jeffrey S.
    Stephens, Philip J.
    Miller, Vincent A.
    Ali, Siraj M.
    Schrock, Alexa B.
    [J]. ONCOLOGIST, 2016, 21 (11) : 1306 - 1314
  • [89] Neuratrophin-regulated signalling pathways
    Reichardt, Louis F.
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2006, 361 (1473) : 1545 - 1564
  • [90] Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers
    Ricarte-Filho, Julio C.
    Li, Sheng
    Garcia-Rendueles, Maria E. R.
    Montero-Conde, Cristina
    Voza, Francesca
    Knauf, Jeffrey A.
    Heguy, Adriana
    Viale, Agnes
    Bogdanova, Tetyana
    Thomas, Geraldine A.
    Mason, Christopher E.
    Fagin, James A.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (11) : 4935 - 4944
45678910111213